Jane Street’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,428,305
Closed -$145M 11957
2025
Q4
$145M Buy
1,428,305
+376,214
+36% +$30.2M 0.02% 447
2025
Q3
$57.6M Buy
1,052,091
+583,340
+124% +$29.1M 0.01% 881
2025
Q2
$24.9M Buy
468,751
+448,451
+2,209% +$22.8M ﹤0.01% 1254
2025
Q1
$879K Sell
20,300
-150,063
-88% -$7.6M ﹤0.01% 5812
2024
Q4
$9.57M Buy
170,363
+75,452
+79% +$4.7M ﹤0.01% 1922
2024
Q3
$6.47M Sell
94,911
-334,762
-78% -$18.9M ﹤0.01% 2451
2024
Q2
$18.2M Buy
429,673
+84,938
+25% +$4.67M ﹤0.01% 1410
2024
Q1
$23.8M Buy
344,735
+138,262
+67% +$8.75M 0.01% 1065
2023
Q4
$15.3M Buy
206,473
+115,452
+127% +$7.57M ﹤0.01% 1520
2023
Q3
$6.21M Sell
91,021
-48,677
-35% -$4.13M ﹤0.01% 2328
2023
Q2
$13.1M Sell
139,698
-17,155
-11% -$1.34M ﹤0.01% 1628
2023
Q1
$10.6M Sell
156,853
-56,252
-26% -$3.62M ﹤0.01% 1581
2022
Q4
$10.6M Buy
213,105
+131,462
+161% +$5.37M ﹤0.01% 1563
2022
Q3
$2.65M Buy
81,643
+1,317
+2% +$54.3K ﹤0.01% 3676
2022
Q2
$3.16M Sell
80,326
-40,732
-34% -$2.18M ﹤0.01% 3362
2022
Q1
$8.46M Sell
121,058
-110,674
-48% -$8.09M ﹤0.01% 2206
2021
Q4
$18M Buy
231,732
+138,943
+150% +$12.3M 0.01% 1297
2021
Q3
$8.86M Buy
92,789
+24,863
+37% +$2.63M ﹤0.01% 1955
2021
Q2
$8.44M Sell
67,926
-15,071
-18% -$1.8M ﹤0.01% 1912
2021
Q1
$10.9M Sell
82,997
-26,719
-24% -$3.66M 0.01% 1463
2020
Q4
$14.5M Buy
109,716
+70,588
+180% +$8.54M 0.01% 1105
2020
Q3
$3.99M Buy
39,128
+17,216
+79% +$1.49M ﹤0.01% 2108
2020
Q2
$1.91M Buy
21,912
+14,928
+214% +$1.19M ﹤0.01% 3133
2020
Q1
$405K Sell
6,984
-176,399
-96% -$14.3M ﹤0.01% 3877
2019
Q4
$17M Buy
183,383
+101,017
+123% +$8.88M 0.02% 437
2019
Q3
$7.44M Buy
82,366
+65,074
+376% +$7.41M 0.01% 738
2019
Q2
$2.04M Sell
17,292
-84,952
-83% -$8.56M ﹤0.01% 1863
2019
Q1
$8.86M Buy
102,244
+86,304
+541% +$7.35M 0.01% 755
2018
Q4
$1.01M Sell
15,940
-9,645
-38% -$662K ﹤0.01% 2551
2018
Q3
$2.02M Sell
25,585
-286,973
-92% -$18.7M ﹤0.01% 1894
2018
Q2
$18.7M Buy
312,558
+306,101
+4,741% +$16.5M 0.04% 330
2018
Q1
$260K Sell
6,457
-13,322
-67% -$650K ﹤0.01% 4185
2017
Q4
$1.04M Buy
19,779
+12,494
+172% +$667K ﹤0.01% 2299
2017
Q3
$343K Sell
7,285
-31,980
-81% -$1.29M ﹤0.01% 3525
2017
Q2
$1.39M Buy
+39,265
New +$1.21M ﹤0.01% 1856
2017
Q1
Sell
-21,000
Closed -$416K 4284
2016
Q4
$281K Sell
21,000
-6,843
-25% -$110K ﹤0.01% 3422
2016
Q3
$517K Sell
27,843
-25,827
-48% -$455K ﹤0.01% 2738
2016
Q2
$657K Buy
53,670
+23,218
+76% +$175K ﹤0.01% 2467
2016
Q1
$205K Buy
30,452
+17,491
+135% +$112K ﹤0.01% 3681
2015
Q4
$120K Buy
+12,961
New +$121K ﹤0.01% 3753
2015
Q1
Sell
-10,685
Closed -$293K 3210
2014
Q4
$293K Sell
10,685
-19,182
-64% -$467K ﹤0.01% 1908
2014
Q3
$579K Buy
+29,867
New +$548K 0.01% 1303
2014
Q2
Sell
-10,263
Closed -$145K 2720
2014
Q1
$145K Sell
10,263
-15,237
-60% -$206K ﹤0.01% 2451
2013
Q4
$300K Buy
+25,500
New +$293K ﹤0.01% 1647
2013
Q3
Sell
-28,758
Closed -$400K 2814
2013
Q2
$400K Buy
+28,758
New +$312K 0.01% 1637

Other funds holding EXAS

Jane Street's EXAS Position: Q1 2026 in Review

Jane Street sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,428,305 shares — an estimated $145M sold.

Jane Street first reported a position in EXAS in Q2 2013 and held it in 45 quarters. The position peaked at $145M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Jane Street reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,428,305 Exact Sciences shares in Q1 2026, an estimated $145M.
  • Jane Street first reported a position in Exact Sciences in Q2 2013 and held it in 45 quarters.
  • Jane Street's Exact Sciences position peaked at $145M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.